Formulation and Characterization of Copper Oxide Solid Lipid Micro-Particles

Authors

  • Slesha Kumar Kosuru Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • Ch. Hemalatha Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • K. Venkat Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • K. Jahnavi Sravanthi Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • V. Kondala Rao Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • M.V.K Tejaswini Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • Santhosh Kumar Gandham Department of Pharmacology, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.

Keywords:

Copper Oxide, Scanning Electron Microscopy, Solid Lipid Micro-Particles, Zeta Potential

Abstract

Aim: The main aim of this study is to evaluate the morphology, particle size, zeta potential and anti-microbial activity of the formulated micro-particles to establish their potential application.

Methods: CuO-SLMs were synthesized using the micro-emulsion-based method by incorporating stearylamine and Tween 80. Characterization was done by SEM analysis and antimicrobial activity was evaluated using pour plate and streaking methods.

Results: SEM confirmed spherical micro-particles with smooth surfaces and a size range of 2 µm, showing good water dispersibility. The CuO-SLMs demonstrated superior antimicrobial activity against both Gram-positive and Gram-negative bacteria compared to standard antibiotic Ciprofloxacin.

Conclusion: This study effectively formulated CuO-MPs utilising the micro-emulsion-based approach. The synthesised micro-particles demonstrated superior spherical shape, a smooth surface and a restricted size distribution within the micrometre scale. The zeta potential study verified the colloidal stability of the formulation, demonstrating little aggregation and effective dispersion in aqueous conditions. Moreover, the CuO-SLMs exhibited substantial antibacterial efficacy against the evaluated bacterial strains, surpassing the conventional antibiotic Ciprofloxacin.

Downloads

Download data is not yet available.

References

Chakraborty S, Shukla D, Mishra B, Singh S. Lipid – An emerging platform for oral delivery of drugs. Eur J Pharm Biopharm. 2009; 73(1): 1-15.

Haque S, Whittaker M, McIntosh MP, Pouton CW, Phipps S, Kaminskas LM. Lung clearance kinetics of SLNs and liposomes. Eur J Pharm Biopharm. 2018; 125: 1-12.

Yun YH, Lee BK, Park K. Controlled Drug Delivery: Historical perspective for the next generation. J Control Release. 2015; 219: 2–7.

Lin CH, Chen CH, Lin ZC, Fang JY. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as carriers. J Food Drug Anal. 2017; 25(2): 219-34.

Costa A, Sarmento B, Seabra V. Mannose-functionalized SLNs for alveolar macrophages targeting. Eur J Pharm Sci. 2018; 114: 103-13.

Ud Din F, Mustapha O, Kim DW, Rashid R, Park JH et al. Novel dual-reverse thermosensitive SLN-loaded hydrogel. Eur J Pharm Biopharm. 2015; 94: 64-72.

Shi L, Li Z, Yu L, Jia H, Zheng L. Effects of surfactants and lipids on SLN preparation. J Dispersion Sci Technol. 2011; 32(2): 254-9.

Teja VRC, Chowdary VH, Raju YP, Surendra N, Vardhan RV, Reddy BK. A Glimpse on solid lipid nanoparticles as drug delivery systems. J Glob Trends Pharm Sci. 2014; 5(2): 1649–57.

Doktorovova S, Souto EB, Silva AM. Hansen solubility parameters for pre-screening formulation of SLNs. Pharm Dev Technol. 2018; 23(1): 96-105.

Pandya JB, Parmar RD, Soniwala MM, Chavda JR. Solid Lipid Nanoparticles: Overview on Excipients. Asian J Pharm Tech Innov. 2013; 1(3):1-9.

Freitas C, Muller RH. Effect of light and temperature on SLN dispersions. Int J Pharm. 1998; 168: 221-9.

Rosiere R, Van Woensel M, Gelbcke M, Mathieu V, Hecq J et al. Folate-grafted chitosan SLNs for lung tumour therapy. Mol Pharm. 2018; 15(3): 899-910.

Shah R, Eldridge D, Palombo E, Harding I. Lipid nanoparticles: Production, characterization and stability. Springer Int Publ. 2015: 11–22.

Sanchez-Lopez E, Espina M, Doktorovova S, Souto EB, García ML. Lipid nanoparticles in ocular delivery. Eur J Pharm Biopharm. 2017; 110: 70-5.

Jannin V, Blas L, Chevrier S, Miolane C, Demarne F, Spitzer D. Evaluation of the digestibility of SLNs of glyceryl dibehenate. Eur J Pharm Sci. 2017;111: 91-5.

Shafique M, Khan MA, Khan WS, Ahmad W, Khan S. Fabrication, Characterization and in vivo Evaluation of Famotidine Loaded Solid Lipid Nanoparticles. J Nanomater. 2017; 2017: 1-9.

Kumar R, Singh A, Garg N, Siril PF. Solid lipid nanoparticles for controlled delivery of poorly water-soluble NSAIDs. Ultrason Sonochem. 2018; 40: 686-96.

Ramalingam P, Ko YT. Enhanced oral delivery of curcumin via surface-modified SLNs. Pharm Res. 2015; 32(2): 389-402.

Baek J, Na Y, Cho C. Sustained cytotoxicity of wogonin via encapsulation in SLNs. Nanomaterials. 2018; 8(3): 159.

Maretti E, Costantino L, Rustichelli C, Leo E, Croce MA et al. SLN assemblies for anti-tuberculosis therapy. Int J Pharm. 2017; 528(1–2): 440-51.

Published

2025-07-31
Statistics
65 Views | 32 Downloads
Citatons

How to Cite

Kosuru, S. K. ., C. . Hemalatha, K. . Venkat, K. J. . Sravanthi, V. . Kondala Rao, M. . Tejaswini, and S. K. . Gandham. “Formulation and Characterization of Copper Oxide Solid Lipid Micro-Particles”. Journal of Clinical and Pharmaceutical Research, vol. 5, no. 3, July 2025, pp. 5-8, https://jcpr.in/index.php/journal/article/view/154.

Issue

Section

Research Articles

Most read articles by the same author(s)

1 2 > >>